Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 52

2.

Detection of antibodies to varicella-zoster virus in recipients of the varicella vaccine by using a luciferase immunoprecipitation system assay.

Cohen JI, Ali MA, Bayat A, Steinberg SP, Park H, Gershon AA, Burbelo PD.

Clin Vaccine Immunol. 2014 Sep;21(9):1288-91. doi: 10.1128/CVI.00250-14. Epub 2014 Jul 2.

3.

Comparative study of the standard fluorescent antibody to membrane antigen (FAMA) assay and a flow cytometry-adapted FAMA assay to assess immunity to varicella-zoster virus.

Lafer MM, Weckx LY, de Moraes-Pinto MI, Garretson A, Steinberg SP, Gershon AA, LaRussa PS.

Clin Vaccine Immunol. 2011 Jul;18(7):1194-7. doi: 10.1128/CVI.05130-11. Epub 2011 May 25.

4.

Effectiveness of 2 doses of varicella vaccine in children.

Shapiro ED, Vazquez M, Esposito D, Holabird N, Steinberg SP, Dziura J, LaRussa PS, Gershon AA.

J Infect Dis. 2011 Feb 1;203(3):312-5. doi: 10.1093/infdis/jiq052.

5.

Evaluation of the time resolved fluorescence immunoassay (TRFIA) for the detection of varicella zoster virus (VZV) antibodies following vaccination of healthcare workers.

McDonald SL, Maple PA, Andrews N, Brown KE, Ayres KL, Scott FT, Al Bassam M, Gershon AA, Steinberg SP, Breuer J.

J Virol Methods. 2011 Mar;172(1-2):60-5. doi: 10.1016/j.jviromet.2010.12.021. Epub 2010 Dec 28.

6.

A phase I-II study of live attenuated varicella-zoster virus vaccine to boost immunity in human immunodeficiency virus-infected children with previous varicella.

Gershon AA, Levin MJ, Weinberg A, Song LY, LaRussa PS, Steinberg SP, Bartlett P; Pediatric AIDS Clinical Trials Group 391 Team.

Pediatr Infect Dis J. 2009 Jul;28(7):653-5. doi: 10.1097/INF.0b013e3181998f06.

7.

Risk of herpes zoster in adults immunized with varicella vaccine.

Hambleton S, Steinberg SP, Larussa PS, Shapiro ED, Gershon AA.

J Infect Dis. 2008 Mar 1;197 Suppl 2:S196-9. doi: 10.1086/522131.

PMID:
18419397
8.

The safety profile of varicella vaccine: a 10-year review.

Galea SA, Sweet A, Beninger P, Steinberg SP, Larussa PS, Gershon AA, Sharrar RG.

J Infect Dis. 2008 Mar 1;197 Suppl 2:S165-9. doi: 10.1086/522125. Review.

PMID:
18419392
9.

Primary vaccine failure after 1 dose of varicella vaccine in healthy children.

Michalik DE, Steinberg SP, Larussa PS, Edwards KM, Wright PF, Arvin AM, Gans HA, Gershon AA.

J Infect Dis. 2008 Apr 1;197(7):944-9. doi: 10.1086/529043.

10.

Severe varicella caused by varicella-vaccine strain in a child with significant T-cell dysfunction.

Jean-Philippe P, Freedman A, Chang MW, Steinberg SP, Gershon AA, LaRussa PS, Borkowsky W.

Pediatrics. 2007 Nov;120(5):e1345-9. Review.

PMID:
17974726
11.

DNA sequence variability in Oka vaccine isolates.

Breuer J, Quinlivan M, Al Bassam M, Macdonald S, Nichols RA, Steinberg SP, Russa PL, Gershon AA.

J Infect Dis. 2007 Sep 1;196(5):801-2; author reply 802-3. No abstract available.

PMID:
17674325
12.

Cholesterol dependence of varicella-zoster virion entry into target cells.

Hambleton S, Steinberg SP, Gershon MD, Gershon AA.

J Virol. 2007 Jul;81(14):7548-58. Epub 2007 May 9.

13.

Natural selection for rash-forming genotypes of the varicella-zoster vaccine virus detected within immunized human hosts.

Quinlivan ML, Gershon AA, Al Bassam MM, Steinberg SP, LaRussa P, Nichols RA, Breuer J.

Proc Natl Acad Sci U S A. 2007 Jan 2;104(1):208-12. Epub 2006 Dec 20.

14.

Vaccine Oka varicella-zoster virus genotypes are monomorphic in single vesicles and polymorphic in respiratory tract secretions.

Quinlivan MA, Gershon AA, Nichols RA, La Russa P, Steinberg SP, Breuer J.

J Infect Dis. 2006 Apr 1;193(7):927-30. Epub 2006 Feb 27.

PMID:
16518753
15.

An evaluation of single nucleotide polymorphisms used to differentiate vaccine and wild type strains of varicella-zoster virus.

Quinlivan M, Gershon AA, Steinberg SP, Breuer J.

J Med Virol. 2005 Jan;75(1):174-80.

PMID:
15543576
16.

Rashes occurring after immunization with a mixture of viruses in the Oka vaccine are derived from single clones of virus.

Quinlivan ML, Gershon AA, Steinberg SP, Breuer J.

J Infect Dis. 2004 Aug 15;190(4):793-6. Epub 2004 Jul 15.

PMID:
15272408
17.

Effectiveness over time of varicella vaccine.

Vázquez M, LaRussa PS, Gershon AA, Niccolai LM, Muehlenbein CE, Steinberg SP, Shapiro ED.

JAMA. 2004 Feb 18;291(7):851-5.

PMID:
14970064
18.

Persistence of immunity to varicella-zoster virus after vaccination of healthcare workers.

Saiman L, LaRussa P, Steinberg SP, Zhou J, Baron K, Whittier S, Della-Latta P, Gershon AA.

Infect Control Hosp Epidemiol. 2001 May;22(5):279-83.

PMID:
11428437
19.

The effectiveness of the varicella vaccine in clinical practice.

Vázquez M, LaRussa PS, Gershon AA, Steinberg SP, Freudigman K, Shapiro ED.

N Engl J Med. 2001 Mar 29;344(13):955-60.

20.

The postmarketing safety profile of varicella vaccine.

Sharrar RG, LaRussa P, Galea SA, Steinberg SP, Sweet AR, Keatley RM, Wells ME, Stephenson WP, Gershon AA.

Vaccine. 2000 Nov 22;19(7-8):916-23.

PMID:
11115716
21.

Varicella vaccine revisited.

LaRussa P, Steinberg SP, Shapiro E, Vazquez M, Gershon AA.

Nat Med. 2000 Dec;6(12):1299-300. No abstract available.

PMID:
11100089
22.

Viral strain identification in varicella vaccinees with disseminated rashes.

LaRussa P, Steinberg SP, Shapiro E, Vazquez M, Gershon AA.

Pediatr Infect Dis J. 2000 Nov;19(11):1037-9. Erratum in: Pediatr Infect Dis J 2001 Jan;20(1):33.

PMID:
11099082
23.

Natural varicella-zoster virus reactivation shortly after varicella immunization in a child.

Kohl S, Rapp J, La Russa P, Gershon AA, Steinberg SP.

Pediatr Infect Dis J. 1999 Dec;18(12):1112-3. No abstract available.

PMID:
10608641
24.

Management of varicella exposures in the neonatal intensive care unit.

Gold WL, Boulton JE, Goldman C, Gershon A, Steinberg SP, Chua R, Low DE, McGeer A.

Pediatr Infect Dis J. 1993 Nov;12(11):954-5. No abstract available.

PMID:
8265289
25.

Restriction fragment length polymorphism of polymerase chain reaction products from vaccine and wild-type varicella-zoster virus isolates.

LaRussa P, Lungu O, Hardy I, Gershon A, Steinberg SP, Silverstein S.

J Virol. 1992 Feb;66(2):1016-20.

27.

Measurement of antibodies to varicella-zoster virus by using a latex agglutination test.

Steinberg SP, Gershon AA.

J Clin Microbiol. 1991 Jul;29(7):1527-9.

28.

Antibodies to varicella-zoster virus glycoproteins I, II, and III in leukemic and healthy children.

LaRussa PS, Gershon AA, Steinberg SP, Chartrand SA.

J Infect Dis. 1990 Sep;162(3):627-33.

PMID:
2167335
31.

Who will treat alcohol and drug abuse patients?

Millman RB, Steinberg SP.

Hosp Community Psychiatry. 1989 Oct;40(10):989. No abstract available.

PMID:
2807215
32.

Varicella-zoster virus glycoprotein oligosaccharides are phosphorylated during posttranslational maturation.

Gabel CA, Dubey L, Steinberg SP, Sherman D, Gershon MD, Gershon AA.

J Virol. 1989 Oct;63(10):4264-76.

33.

Varicella-zoster virus infections in children infected with human immunodeficiency virus.

Jura E, Chadwick EG, Josephs SH, Steinberg SP, Yogev R, Gershon AA, Krasinski KM, Borkowsky W.

Pediatr Infect Dis J. 1989 Sep;8(9):586-90.

PMID:
2797953
34.

Herpes zoster in an adult recipient of live attenuated varicella vaccine.

Hammerschlag MR, Gershon AA, Steinberg SP, Clarke L, Gelb LD.

J Infect Dis. 1989 Sep;160(3):535-7. Erratum in: J Infect Dis 1989 Dec;160(6):1095.

PMID:
2547882
35.
36.

Immunization of healthy adults with live attenuated varicella vaccine.

Gershon AA, Steinberg SP, LaRussa P, Ferrara A, Hammerschlag M, Gelb L.

J Infect Dis. 1988 Jul;158(1):132-7. Erratum in: J Infect Dis 1988 Nov;158(5):1149.

PMID:
2839577
37.

Western blot analysis of antibody to varicella-zoster virus.

Dubey L, Steinberg SP, LaRussa P, Oh P, Gershon AA.

J Infect Dis. 1988 May;157(5):882-8.

PMID:
2834466
38.

The risk of zoster after varicella vaccination in children with leukemia.

Lawrence R, Gershon AA, Holzman R, Steinberg SP.

N Engl J Med. 1988 Mar 3;318(9):543-8.

PMID:
2828948
39.

Rapid enzyme-linked immunosorbent assay for detecting antibody to varicella-zoster virus.

Demmler GJ, Steinberg SP, Blum G, Gershon AA.

J Infect Dis. 1988 Jan;157(1):211-2. No abstract available.

PMID:
2826610
40.

Molecular epidemiology of live, attenuated varicella virus vaccine in children with leukemia and in normal adults.

Gelb LD, Dohner DE, Gershon AA, Steinberg SP, Waner JL, Takahashi M, Dennehy PH, Brown AE.

J Infect Dis. 1987 Apr;155(4):633-40.

PMID:
3029239
41.

Live attenuated varicella vaccine use in immunocompromised children and adults.

Gershon AA, Steinberg SP, Gelb L.

Pediatrics. 1986 Oct;78(4 Pt 2):757-62.

PMID:
3020495
42.

Determination of immunity to varicella-zoster virus by means of an intradermal skin test.

LaRussa P, Steinberg SP, Seeman MD, Gershon AA.

J Infect Dis. 1985 Nov;152(5):869-75.

PMID:
2995511
43.

Live attenuated varicella vaccine. Efficacy for children with leukemia in remission.

Gershon AA, Steinberg SP, Gelb L, Galasso G, Borkowsky W, LaRussa P, Farrara A.

JAMA. 1984 Jul 20;252(3):355-62.

PMID:
6330386
44.

Clinical reinfection with varicella-zoster virus.

Gershon AA, Steinberg SP, Gelb L.

J Infect Dis. 1984 Feb;149(2):137-42.

PMID:
6321605
45.

Evaluation of the anticomplement immunofluorescence test for detection of antibody to varicella-zoster virus.

Preissner CM, Steinberg SP, Gershon AA, Smith TF.

J Clin Microbiol. 1982 Aug;16(2):373-6.

46.

IgM to varicella-zoster virus: demonstration in patients with and without clinical zoster.

Gershon AA, Steinberg SP, Borkowsky W, Lennette D, Lennette E.

Pediatr Infect Dis. 1982 May-Jun;1(3):164-7.

PMID:
6292875
47.
48.

Antibody responses to varicella-zoster virus and the role of antibody in host defense.

Gershon AA, Steinberg SP.

Am J Med Sci. 1981 Jul-Aug;282(1):12-7.

PMID:
6267940
49.

Rapid diagnosis of varicella-zoster virus infections by countercurrent immunoelectrophoresis.

Frey HM, Steinberg SP, Gershon AA.

J Infect Dis. 1981 Feb;143(2):274-80.

PMID:
6260875
50.

Determination of immunity to varicella using an enzyme-linked-immunosorbent-assay.

Gershon AA, Frey HM, Steinberg SP, Seeman MD, Bidwell D, Voller A.

Arch Virol. 1981;70(2):169-72. No abstract available.

PMID:
6277288

Supplemental Content

Loading ...
Support Center